134 related articles for article (PubMed ID: 35574021)
1. Corrigendum: Antithyroglobulin Antibody Variation During Follow-Up Has a Good Prognostic Value for Preoperative Antithyroglobulin Antibody-Positive Differentiated Thyroid Cancer Patients: A Retrospective Study in Southwest China.
Liu Q; Yin M; Li G
Front Endocrinol (Lausanne); 2022; 13():899184. PubMed ID: 35574021
[TBL] [Abstract][Full Text] [Related]
2. Investigating Antithyroglobulin Antibody As a Prognostic Marker for Differentiated Thyroid Cancer: A Meta-Analysis and Systematic Review.
Lee ZJO; Eslick GD; Edirimanne S
Thyroid; 2020 Nov; 30(11):1601-1612. PubMed ID: 32345152
[No Abstract] [Full Text] [Related]
3. Prognostic value and dynamics of antithyroglobulin antibodies for differentiated thyroid carcinoma.
Sun D; Zheng X; He X; Huang C; Jia Q; Tan J; Zheng W; Li N; Wang P; Wang R; Liu M; Zhao L; Yuan S; Meng Z; Fan Y
Biomark Med; 2020 Dec; 14(18):1683-1692. PubMed ID: 33346697
[No Abstract] [Full Text] [Related]
4. Prognosis of differentiated thyroid cancer in relation to serum thyrotropin and thyroglobulin antibody status at time of diagnosis.
McLeod DS; Cooper DS; Ladenson PW; Ain KB; Brierley JD; Fein HG; Haugen BR; Jonklaas J; Magner J; Ross DS; Skarulis MC; Steward DL; Maxon HR; Sherman SI;
Thyroid; 2014 Jan; 24(1):35-42. PubMed ID: 23731273
[TBL] [Abstract][Full Text] [Related]
5. Monitoring differentiated thyroid cancer patients with negative serum thyroglobulin. Diagnostic implication of TSH-stimulated antithyroglobulin antibody.
Nam HY; Paeng JC; Chung JK; Kang KW; Cheon GJ; Kim Y; Park DJ; Park YJ; Min HS; Lee DS
Nuklearmedizin; 2014; 53(2):32-8. PubMed ID: 24276613
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcome of patients with differentiated thyroid cancer and raised antithyroglobulin antibody levels: a retrospective study.
Ora M; Nazar AH; Mishra P; Barai S; Arya A; Pradhan PK; Gambhir S
Thyroid Res; 2021 Apr; 14(1):8. PubMed ID: 33858456
[TBL] [Abstract][Full Text] [Related]
7. The additive clinical value of 18F-FDG PET/CT in defining the recurrence of disease in patients with differentiated thyroid cancer who have isolated increased antithyroglobulin antibody levels.
Ozkan E; Soydal C; Araz M; Aras G; Ibis E
Clin Nucl Med; 2012 Aug; 37(8):755-8. PubMed ID: 22785502
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of Basal Serum Thyroglobulin Levels, but Not Basal Antithyroglobulin Antibody (TgAb) Levels, in Patients with Differentiated Thyroid Cancer.
Neshandar Asli I; Siahkali AS; Shafie B; Javadi H; Assadi M
Mol Imaging Radionucl Ther; 2014 Jun; 23(2):54-9. PubMed ID: 24963446
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of preoperative anti-thyroglobulin antibody in differentiated thyroid cancer.
Jo K; Kim MH; Ha J; Lim Y; Lee S; Bae JS; Jung CK; Kang MI; Cha BY; Lim DJ
Clin Endocrinol (Oxf); 2017 Sep; 87(3):292-299. PubMed ID: 28493284
[TBL] [Abstract][Full Text] [Related]
10. Implications of thyroglobulin antibody positivity in patients with differentiated thyroid cancer: a clinical position statement.
Verburg FA; Luster M; Cupini C; Chiovato L; Duntas L; Elisei R; Feldt-Rasmussen U; Rimmele H; Seregni E; Smit JW; Theimer C; Giovanella L
Thyroid; 2013 Oct; 23(10):1211-25. PubMed ID: 23692026
[TBL] [Abstract][Full Text] [Related]
11. Role of Tc-99m pertechnetate for remnant scintigraphy, post-thyroidectomy, and serum thyroglobulin and antithyroglobulin antibody levels in the patients with differentiated thyroid cancer.
Aydin F; Sipahi M; Budak ES; Oner AO; Demirelli S; Erkilic M; Gungor F
Ann Nucl Med; 2016 Jan; 30(1):60-7. PubMed ID: 26462671
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of elevated level of serum antithyroglobulin antibody in patients with differentiated thyroid cancer after thyroid ablation.
Chung JK; Park YJ; Kim TY; So Y; Kim SK; Park DJ; Lee DS; Lee MC; Cho BY
Clin Endocrinol (Oxf); 2002 Aug; 57(2):215-21. PubMed ID: 12153600
[TBL] [Abstract][Full Text] [Related]
13. Utility of 8F-FDG PET/CT in well differentiated thyroid carcinoma with high serum antithyroglobulin antibody.
Kingpetch K; Pipatrattana R; Tepmongkol S; Sirisalipoch S; Chaiwatanarat T
J Med Assoc Thai; 2011 Oct; 94(10):1238-44. PubMed ID: 22145510
[TBL] [Abstract][Full Text] [Related]
14. [Clinical significance of serum thyroglobulin and antithyroglobulin antibody in differentiated thyroid cancer after thyroid ablation].
Vincze B; Sinkovics I; Keresztes S; Gergye M; Boér A; Remenár E; Péter I; Szentirmay Z; Kremmer T; Kásler M
Magy Onkol; 2004; 48(1):27-34. PubMed ID: 15105893
[TBL] [Abstract][Full Text] [Related]
15. [Influence of endogenous TgAb upon serum Tg measurement results and Tg positive rate in patients with differentiated thyroid carcinoma].
Zhang W; Deng H; Pan M; Huang R; Tang G
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2013 Aug; 30(4):803-7. PubMed ID: 24059060
[TBL] [Abstract][Full Text] [Related]
16. Correlation of 18F-FDG PET/CT findings with histopathological results in differentiated thyroid cancer patients who have increased thyroglobulin or antithyroglobulin antibody levels and negative 131I whole-body scan results.
Ozkan E; Aras G; Kucuk NO
Clin Nucl Med; 2013 May; 38(5):326-31. PubMed ID: 23486319
[TBL] [Abstract][Full Text] [Related]
17. [A retrospective cohort study of patients diagnosed of thyroid cancer in the southwest Madrid area. Predictive factors in differentiated thyroid cancer].
Donnay Candil S; Gorgojo Martínez JJ; Requejo Salinas H; López Hernández E; Almodóvar Ruiz F; Mitjavila Casanovas M; Pinedo Moraleda F
Endocrinol Nutr; 2013 Feb; 60(2):60-8. PubMed ID: 22963891
[TBL] [Abstract][Full Text] [Related]
18. Initial Size of Metastatic Lesions Is Best Prognostic Factor in Patients with Metastatic Differentiated Thyroid Carcinoma Confined to the Lung.
Kim M; Kim WG; Park S; Kwon H; Jeon MJ; Lee JJ; Ryu JS; Kim TY; Shong YK; Kim WB
Thyroid; 2017 Jan; 27(1):49-58. PubMed ID: 27750021
[TBL] [Abstract][Full Text] [Related]
19. Change in Antithyroglobulin Antibody Levels is a Good Predictor of Responses to Therapy in Antithyroglobulin Antibody-Positive Pediatric Papillary Thyroid Carcinoma Patients.
Xi C; Zhang GQ; Song HJ; Shen CT; Hou LY; Qiu ZL; Luo QY
Int J Endocrinol; 2022; 2022():7173919. PubMed ID: 35311033
[TBL] [Abstract][Full Text] [Related]
20. Prevalence, clinical significance and prognostic value of anti-thyroglobulin antibodies in the follow-up of patients with differentiated thyroid carcinoma: a retrospective study.
Pedrazzini L; Baroli A; Lomuscio G; Marzoli L
Minerva Endocrinol; 2009 Sep; 34(3):195-203. PubMed ID: 19859043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
